CAR-M Technology: A Novel Approach to Overcome CAR-T Limitations in Solid Tumor Treatment
The Dawn of CAR-M: Revolutionizing Cancer Treatment In a groundbreaking study led by Dr. Chi Hoon Park at the Korea Research Institute of Chemical Technology (KRICT), researchers have introduced a novel cancer immunotherapy called CAR-M, leveraging the potential of macrophages in fighting solid tumors. This innovative approach surmounts the limitations faced by traditional CAR-T cell … Read more